CRL
Charles River Laboratories Inte · Healthcare · Diagnostics & Research
TECHStrong BuyZACKSBuy
R500#125 today
$290.19
+1.17% today · -0.90% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- CRL +1.17% on the last session vs SPY +0.74%: +0.4 pts of stock-specific move.
- Aftermath, big drop (Oct 1): After its 58 big drops in the past 5 years, CRL typically gained 0.4% over the next day (median) and was higher 60% of the time; half the outcomes fell between -0.7% and +1.5%. An ordinary day: -0.0%. Among S&P 500 stocks after big drops, that ranks #139 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Nov 4
In 31 days
estimated date
EPS estimate
$2.96
$2.92 to $3.09 · 12 analysts
Revenue estimate
$959.8M
$951.3M to $984.2M
Track record
8/8 beats
last 8 reports · moved ±8.3% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 BMO | 2Q2026 | $2.74 | $3.02 | +$0.28 (+10.3%) beat | $1.0B | +11.4% +11.6 vs SPY | +14.5% | +20.4% |
| May 7, 2026 BMO | 1Q2026 | $1.95 | $2.06 | +$0.11 (+5.4%) beat | $995.8M | 0.0% +0.3 vs SPY | +4.2% | -10.4% |
| Feb 18, 2026 BMO | 4Q2025 | $2.35 | $2.39 | +$0.04 (+1.9%) beat | $994.2M | -0.3% -0.8 vs SPY | -7.4% | +4.8% |
| Nov 5, 2025 BMO | 3Q2025 | $2.34 | $2.43 | +$0.09 (+3.9%) beat | $1.0B | -5.7% -6.1 vs SPY | -8.2% | -2.5% |
| Aug 6, 2025 BMO | $2.55 | $3.12 | +$0.57 (+22.4%) beat | — | -10.2% -11.0 vs SPY | -6.2% | -8.8% | |
| May 7, 2025 BMO | $2.07 | $2.34 | +$0.27 (+13.0%) beat | — | +18.7% +18.3 vs SPY | +22.2% | +24.8% | |
| Feb 19, 2025 BMO | $2.53 | $2.66 | +$0.13 (+5.1%) beat | — | +6.9% +6.6 vs SPY | +3.2% | +8.2% | |
| Nov 6, 2024 BMO | $2.42 | $2.59 | +$0.17 (+7.0%) beat | — | +13.5% +11.0 vs SPY | +21.4% | +14.4% | |
| Aug 7, 2024 BMO | $2.39 | $2.80 | +$0.41 (+17.2%) beat | — | -12.6% -11.9 vs SPY | -16.1% | -11.1% | |
| May 9, 2024 BMO | $2.06 | $2.27 | +$0.21 (+10.2%) beat | — | -2.2% -2.8 vs SPY | +0.3% | -1.2% | |
| Feb 14, 2024 BMO | $2.40 | $2.46 | +$0.06 (+2.5%) beat | — | +11.3% +10.4 vs SPY | +3.0% | +9.5% | |
| Nov 8, 2023 BMO | $2.37 | $2.72 | +$0.35 (+14.8%) beat | — | -3.7% -3.8 vs SPY | -2.1% | -2.4% | |
| Aug 9, 2023 BMO | $2.64 | $2.69 | +$0.05 (+1.9%) beat | — | +4.6% +5.3 vs SPY | +2.9% | +1.9% | |
| May 11, 2023 BMO | $2.59 | $2.78 | +$0.19 (+7.3%) beat | — | +5.1% +5.2 vs SPY | +1.7% | +5.6% | |
| Feb 22, 2023 BMO | $2.75 | $2.98 | +$0.23 (+8.4%) beat | — | -10.1% -9.9 vs SPY | -11.5% | -10.0% | |
| Nov 2, 2022 BMO | $2.50 | $2.63 | +$0.13 (+5.2%) beat | — | +4.1% +6.6 vs SPY | +7.2% | +7.3% | |
| Aug 3, 2022 BMO | $2.74 | $2.77 | +$0.03 (+1.1%) beat | — | -9.1% -10.7 vs SPY | -10.2% | -12.0% | |
| May 4, 2022 BMO | $2.72 | $2.75 | +$0.03 (+1.1%) beat | — | +2.5% -0.5 vs SPY | +5.5% | -8.7% | |
| Feb 16, 2022 BMO | $2.43 | $2.49 | +$0.06 (+2.5%) beat | — | -2.4% -2.5 vs SPY | -6.0% | -9.3% | |
| Nov 3, 2021 BMO | $2.58 | $2.70 | +$0.12 (+4.7%) beat | — | -10.2% -10.8 vs SPY | -5.1% | -11.2% | |
| Aug 4, 2021 BMO | $2.38 | $2.61 | +$0.23 (+9.7%) beat | — | — | — | — | |
| May 4, 2021 BMO | $2.19 | $2.53 | +$0.34 (+15.5%) beat | — | — | — | — | |
| Feb 17, 2021 BMO | $2.11 | $2.39 | +$0.28 (+13.3%) beat | — | — | — | — | |
| Oct 29, 2020 BMO | $1.80 | $2.33 | +$0.53 (+29.4%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $2.96 (12) | $2.92 – $3.09 | +22% | -2.6% | ▲2 ▼0 | $959.8M | -4% |
| Next quarter · Dec 31, 2026 | $3.32 (12) | $3.00 – $3.46 | +39% | +2.5% | ▲1 ▼1 | $955.5M | -4% |
| Current year · Dec 31, 2026 | $11.35 (17) | $11.02 – $11.49 | +10% | +2.3% | ▲2 ▼1 | $3.9B | -2% |
| Next year · Dec 31, 2027 | $12.74 (17) | $11.70 – $13.68 | +12% | +3.4% | ▲5 ▼2 | $4.0B | +2% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.